1623 Capital LLC Iveric Bio, Inc. Transaction History

1623 Capital LLC

  • $186 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$12.15 - $16.83 $243,000 - $336,599
-20,000 Closed
0 $0
Q4 2021

Feb 11, 2022
SELL
$13.83 - $18.78 $556,422 - $755,575
-40,233 Reduced 66.8%
20,000 $334,000
Q3 2021

Nov 12, 2021
BUY
$7.07 - $17.5 $425,847 - $1.05 Million
60,233 New
60,233 $978,000

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track 1623 Capital LLC Portfolio

Follow 1623 Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1623 Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on 1623 Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email